Major histocompatibility complex class II is linked to better prognosis of cancer patients, and its expression on cancer cells depends on the trans activator CIITA, which is inactivated in colorectal and gastric cancers [56], hence attributing tumour suppressor function to CIITA [53]. Here, CIITA is linked to neoplasm.